acrinathrin: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 6436606 |
| CHEMBL ID | 2287507 |
| CHEBI ID | 39091 |
| SCHEMBL ID | 63236 |
| MeSH ID | M0306075 |
| Synonym |
|---|
| cy6clopropanecarboxylic acid, 2,2-dimethyl-3-(3-oxo-3-(2,2,2-trifluoro-1-(trifluoromethyl)ethoxy)-1-propenyl)-, cyano(3-phenoxyphenyl)methyl ester, (1r-(1alpha(s*),3alpha(z)))- |
| acrinathrin [iso] |
| 101007-06-1 |
| CHEBI:39091 , |
| (s)-cyano(3-phenoxyphenyl)methyl (1r,3s)-2,2-dimethyl-3-{(1z)-3-oxo-3-[2,2,2-trifluoro-1-(trifluoromethyl)ethoxy]prop-1-en-1-yl}cyclopropanecarboxylate |
| acrinathrin |
| [(s)-cyano-(3-phenoxyphenyl)methyl] (1r,3s)-3-[(z)-3-(1,1,1,3,3,3-hexafluoropropan-2-yloxy)-3-oxoprop-1-enyl]-2,2-dimethylcyclopropane-1-carboxylate |
| C18408 |
| unii-qui1az37k6 |
| qui1az37k6 , |
| (s)-cyano(3-phenoxyphenyl)methyl (z)-(1r,3s)-2,2-dimethyl[2-(2,2,2-trifluoro-1-trifluoromethylethoxycarbonyl)vinyl]-cyclopropanecarboxylate |
| agrevo |
| orytis |
| acrinathrin [mi] |
| acr-50 |
| cyclopropanecarboxylic acid, 2,2-dimethyl-3-((1z)-3-oxo-3-(2,2,2-trifluoro-1-(trifluoromethyl)ethoxy)-1-propen-1-yl)-, (s)-cyano(3-phenoxyphenyl)methyl ester, (1r,3s)- |
| ru-38702 |
| SCHEMBL63236 |
| CHEMBL2287507 |
| DTXSID3041584 |
| J-000301 |
| acrinathrin, pestanal(r), analytical standard |
| cyclopropanecarboxylic acid, 2,2-dimethyl-3-[(1z)-3-oxo-3-[2,2,2-trifluoro-1-(trifluoromethyl)ethoxy]-1-propen-1-yl]-, (s)-cyano(3-phenoxyphenyl)methyl ester, (1r,3s)- |
| acrinathrin 10 microg/ml in cyclohexane |
| acrinathrin 100 microg/ml in cyclohexane |
| (s)-cyano(3-phenoxyphenyl)methyl (z)-(1r,3s)-2,2-dimethyl-3-{2-[2,2,2-trifluoro-1- (trifluoromethyl)ethoxycarbonyl]vinyl}cyclopropane-1-carboxylate |
| YLFSVIMMRPNPFK-WEQBUNFVSA-N , |
| Q342726 |
| CS-0110215 |
| Role | Description |
|---|---|
| pyrethroid ester insecticide | null |
| pyrethroid ester acaricide | null |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Class | Description |
|---|---|
| cyclopropanecarboxylate ester | A carboxylic ester resulting from the formal condensation of the hydroxy group of an alcohol or phenol with the carboxy group of cyclopropanecarboxylic acid or its substituted derivatives. |
| organofluorine compound | An organofluorine compound is a compound containing at least one carbon-fluorine bond. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1111941 | Insecticidal activity against Frankliniella occidentalis MLFOM (western flower thrips) | 2011 | Pest management science, Dec, Volume: 67, Issue:12 | Esterase inhibition by synergists in the western flower thrips Frankliniella occidentalis. |
| AID1111937 | Resistance ratio, LC50 for Frankliniella occidentalis MLFOM (western flower thrips) to LC50 for Frankliniella occidentalis ACR | 2011 | Pest management science, Dec, Volume: 67, Issue:12 | Esterase inhibition by synergists in the western flower thrips Frankliniella occidentalis. |
| AID1111940 | Insecticidal activity against Frankliniella occidentalis ACR (western flower thrips) | 2011 | Pest management science, Dec, Volume: 67, Issue:12 | Esterase inhibition by synergists in the western flower thrips Frankliniella occidentalis. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 9 (60.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (35.60) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 16 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||